Dr. Stein on Targeted Therapies for Melanoma

Jennifer A. Stein, MD, PhD
Published: Thursday, Aug 03, 2017



Jennifer A. Stein, MD, PhD, an associate professor of dermatology at NYU Langone Medical Center, discusses targeted therapies for patients with melanoma.

With the BRAF inhibitors, patients can get new skin cancers, particularly squamous cell carcinomas, explains Stein.

Those squamous cell carcinomas are usually seen in older patients, people with fair skin, or those who have had a lot of exposure to the sun, states Stein.
 


Jennifer A. Stein, MD, PhD, an associate professor of dermatology at NYU Langone Medical Center, discusses targeted therapies for patients with melanoma.

With the BRAF inhibitors, patients can get new skin cancers, particularly squamous cell carcinomas, explains Stein.

Those squamous cell carcinomas are usually seen in older patients, people with fair skin, or those who have had a lot of exposure to the sun, states Stein.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Community Practice Connections™: 13th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®Apr 28, 20182.0
Publication Bottom Border
Border Publication
x